Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2024-03-27 Governance Information
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of the Nomination Committee of the Board' for Pharmaron Beijing Co., Ltd. It details the responsibilities, composition, procedures, and governance of the Nomination Committee, which is a board committee responsible for nominating directors and senior management. The content focuses on governance structure and internal rules related to board nominations rather than financial data, meeting transcripts, or announcements of voting results. It is not an annual report, earnings release, or any financial report. It is also not a proxy solicitation or voting results announcement. The document is a governance-related report detailing internal rules and committee functions, which fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance procedures, not just an announcement or summary, so it is not RPA or RNS. Therefore, the appropriate classification is Governance Information (CGR).
2024-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-03-27 English
FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 2023
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Cash Dividend Announcement for Equity Issuer' and provides details about a final dividend for the year ended December 31, 2023. It includes dividend amount, type, and related dates, although some dates are 'To be announced'. The document is short (3175 characters) and focuses solely on dividend information without financial statements or broader financial performance data. It is not a full annual or interim report, nor a regulatory filing or announcement of a report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2024-03-27 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023' and contains detailed consolidated financial statements including profit or loss, comprehensive income, financial position, segment revenue and results, and notes to the consolidated financial statements. It covers the full fiscal year ended December 31, 2023, and includes extensive financial data and analysis. The length of the document (15,000 characters) and the presence of full financial statements indicate this is the actual annual report rather than a brief announcement or summary. The document is not a short announcement stating a report is attached or published elsewhere, nor is it a certification or a regulatory filing. Therefore, it fits the definition of an Annual Report (10-K equivalent). FY 2023
2024-03-27 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a notice announcing a forthcoming board meeting to consider and approve the annual results and dividend recommendation. It does not contain the actual annual report or financial results but is an announcement of a meeting where such matters will be discussed. The document is short (1543 characters) and serves as a formal notification rather than a report or detailed financial disclosure. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than the Annual Report (10-K) or any other specific report type.
2024-03-13 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-03-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.